10 | CFHN
centralfloridahealthnews.com
While that increase is enough to get the at-
tention of researchers and physicians, Wat-
son Clinic’s Dr. Elisabeth Dupont says it has 
not translated into a dramatic shift in what 
she sees day to day.
“Because the rate of increase has been slow 
and low, I have not really appreciated a ma-
jor change,” she says. “I have always had 
young patients.
Dupont recalls treating a 25-year-old about 
20 years ago who is still doing well today. 
What has changed, Dupont says, is how 
much attention breast cancer in younger 
women receives.
“I would guess in the past 10 years, it has 
been more on my mind,” she says.
DIFFERENT AGES, DIFFERENT 
CHALLENGES
Breast cancer at a younger age can differ 
from breast cancer diagnosed later in life. 
Dupont says younger patients are more 
likely to be diagnosed with aggressive sub-
types, including triple-negative, HER2-posi-
tive and hormone-negative breast cancers.
Screening also presents a set of its own 
challenges. Most women younger than 40 
are not yet undergoing routine mammog-
raphy, and younger women frequently have 
dense breast tissue, which can make it more 
difficult to detect cancer on mammograms.
In addition, Dupont says high-risk surveil-
lance programs have become more com-
mon, along with an overall greater public 
awareness.
“Today we talk about it, where in the past it 
was taboo,” she says.
Younger women may also experience con-
cerns that differ from those of older breast 
cancer patients. Treatment can affect fer-
tility and can also potentially contribute to 
early menopause or sexual dysfunction.
Many of the younger patients are also rais-
ing children and building careers for them-
selves. Navigating financial responsibilities 
is another obstacle they grapple with while 
undergoing treatment. 
In addition, Dupont adds, younger breast 
cancer survivors have a higher prevalence 
of psychosocial issues, such as anxiety and 
depression.
KNOW YOUR PERSONAL RISK
While family history matters, Dupont says 
genetics play a smaller role than what many 
assume.
“Genetic influence is not as common as 
people think,” she says. “Still, most people 
with breast cancer do not carry a gene.”
She adds that if a younger patient has a 
strong family history of breast or ovarian 
cancer or genetic mutations associated 
with breast cancer, she recommends closer 
monitoring or earlier screening. 
Dupont says many experts recommend 
ADVERTORIAL
HEART
NEWS
M
icroplastics and nano-
plastics are increasing 
your cardiovascular risk.
The production of plastics 
is 
constantly 
increasing 
and this is set to continue 
through 2050. Plastics can 
permeate the environment 
by way of ocean currents, 
atmospheric 
winds 
and 
terrestrial 
phenomena, 
contributing 
to 
their 
widespread distribution. Once released into nature, 
plastics are susceptible to degradation, leading to 
the formation of microplastics, defined as particles 
smaller than 5 mm, and nanoplastics, defined as 
particles smaller than 1000 nanometers. Both types 
of particles trigger a range of toxic effects.
Several 
research 
studies 
have 
shown 
that 
microplastics and nanoplastics (MNPs) enter the 
human body through eating, breathing, and skin 
exposure, where they interact with tissues and 
organs. MNPs have been found in selected human 
tissues, such as the placenta, lungs, and liver, as 
well as in breastmilk, urine, and blood. Recent 
studies performed in preclinical settings have led 
to the suggestion of MNPs as a new risk factor for 
cardiovascular diseases. They do this by promoting 
oxidative stress, inflammation, and programmed cell 
death in endothelial and other vascular cells in the 
blood vessels. Studies done in animals showed that 
MNPs change the heart rate and cause impairment 
of heart function, fibrosis in heart muscles, and 
remote dysfunction of blood vessel cells.
Recent studies have shown there is an association 
between the burden of MNPs and cardiovascular 
disease. Atherosclerotic plaque was detected in 
surgical samples from the carotid artery. Subsequent 
studies confirmed that patients with MNPs in the 
plaque in their carotid artery had a higher risk of 
having a heart attack, stroke, or death from any caus 
e compared to patients whose carotid artery sample 
did not have MNPs in the plaque.  
BIO: Dr. Kollagunta Chandrasekhar, better known as Dr. Sekhar 
(pronounced Shaker) has been practicing cardiology in Winter Haven for 
more than 25 years. 
This column is sponsored by KSC Cardiology, and the opinions expressed 
herein may not reflect those of CFHN or of its advertisers.
DR. RITU APARAJITA 
KSC Cardiology
Microplastics Pose Growing  
Threat to Heart Health
EDITION
FEATURE
Watson Clinic Doctor 
Discusses Increase in  
Diagnoses in Younger 
Women 
by SHAYLYNN MARKS
B
reast cancer is far more common in older women, but data from the most recent decade 
of data shows diagnoses among women younger than 50 have been slowly increasing 
by about 1.4% each year.
Breast Cancer 
Before 50

View this content as a flipbook by clicking here.